Go Pro

247,454 Shares in Synopsys, Inc. $SNPS Acquired by Caisse de depot et placement du Quebec

Synopsys logo with Technology background
Image from MarketBeat Media, LLC.

Caisse de depot et placement du Quebec bought a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 247,454 shares of the semiconductor company's stock, valued at approximately $110,382,000. Caisse de depot et placement du Quebec owned 0.13% of Synopsys at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. Sankala Group LLC bought a new position in shares of Synopsys in the fourth quarter worth $25,000. Elevation Wealth Partners LLC raised its stake in shares of Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock valued at $25,000 after purchasing an additional 27 shares in the last quarter. Osbon Capital Management LLC bought a new stake in shares of Synopsys during the second quarter valued at about $25,000. IMG Wealth Management Inc. bought a new stake in shares of Synopsys during the second quarter valued at about $28,000. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in Synopsys in the fourth quarter worth about $28,000. Institutional investors own 85.47% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on SNPS shares. Piper Sandler upgraded shares of Synopsys from a "neutral" rating to an "overweight" rating and increased their target price for the company from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Weiss Ratings restated a "hold (c-)" rating on shares of Synopsys in a research report on Monday, June 8th. Zacks Research lowered shares of Synopsys from a "strong-buy" rating to a "hold" rating in a research note on Friday, August 21st. Morgan Stanley decreased their price objective on shares of Synopsys from $525.00 to $500.00 and set an "equal weight" rating for the company in a report on Wednesday, August 19th. Finally, Benchmark reiterated a "buy" rating on shares of Synopsys in a research note on Wednesday, August 19th. Eleven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Synopsys currently has a consensus rating of "Moderate Buy" and a consensus target price of $563.59.

Get Our Latest Stock Report on SNPS

Insiders Place Their Bets

In other news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the firm's stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares of the company's stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by corporate insiders.

Synopsys Stock Performance

Synopsys stock opened at $410.00 on Thursday. The firm's 50 day simple moving average is $416.71 and its 200-day simple moving average is $439.84. The company has a market cap of $78.51 billion, a P/E ratio of 94.91, a price-to-earnings-growth ratio of 2.40 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $615.79.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating the consensus estimate of $3.67 by $0.24. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The business had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same quarter in the prior year, the firm earned $3.39 EPS. The firm's quarterly revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, equities research analysts predict that Synopsys, Inc. will post 10.64 EPS for the current year.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Synopsys reported fiscal Q3 revenue of $2.477 billion, up 42.4% year over year, while non-GAAP EPS of $3.91 exceeded the $3.67 consensus estimate. Design Automation was the primary contributor, indicating broad demand for chip-design software. Synopsys Posts Financial Results for Third Quarter Fiscal Year 2026
  • Positive Sentiment: Management raised its fiscal 2026 outlook to approximately $9.715 billion in revenue and $15.07 in non-GAAP EPS at the midpoints. The company also projected fourth-quarter EPS of $4.10-$4.16, above the $3.78 analyst consensus, citing continued AI-driven demand and benefits from the Ansys business. Synopsys raises annual forecasts on AI-driven chip design software demand
  • Positive Sentiment: Synopsys continues to position AI as a growth driver, saying customers are achieving substantial productivity gains and that engineering workflows are moving toward more autonomous systems. Nvidia’s reported $2 billion investment in Synopsys also reinforces the strategic importance of AI-powered design and simulation. Nvidia's $2 Billion Synopsys Bet Signals AI's Next Frontier
  • Neutral Sentiment: Analyst sentiment remains favorable: Rosenblatt reaffirmed a Buy rating and set a $575 price target. However, SNPS trades at a high earnings multiple, leaving the shares sensitive to guidance, execution and valuation concerns. Rosenblatt Reiterates Buy Rating on Synopsys
  • Negative Sentiment: The stock declined even after the earnings beat and guidance increase. The reaction indicates that strong results may already have been priced in, while full-year revenue guidance was broadly aligned with expectations and fourth-quarter revenue guidance of $2.53-$2.58 billion did not clearly exceed consensus. Synopsys slides even as it boosts full-year guidance

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines